Ex vivo behaviour of human bone tumor endothelial cells

Teresa Infante, Elena Cesario, Michele Gallo, Flavio Fazioli, Annarosaria De Chiara, Cristina Tutucci, Gaetano Apice, Filomena de Nigris

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cooperation between endothelial cells and bone in bone remodelling is well established. In contrast, bone microvasculature supporting the growth of primary tumors and metastasis is poorly understood. Several antiangiogenic agents have recently been undergoing trials, although an extensive body of clinical data and experimental research have proved that angiogenic pathways differ in each tumor type and stage. Here, for the first time, we characterize at the molecular and functional level tumor endothelial cells from human bone sarcomas at different stages of disease and with different histotypes. We selected a CD31 + subpopulation from biopsies that displayed the capability to grow as adherent cell lines without vascular endothelial growth factor (VEGF). Our findings show the existence in human primary bone sarcomas of highly proliferative endothelial cells expressing CD31, CD44, CD105, CD146 and CD90 markers. These cells are committed to develop capillary-like structures and colony formation units, and to produce nitric oxide. We believe that a better understanding of tumor vasculature could be a valid tool for the design of an efficacious antiangiogenic therapy as adjuvant treatment of sarcomas.

Original languageEnglish
Pages (from-to)404-417
Number of pages14
JournalCancers
Volume5
Issue number2
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Endothelial Cells
Sarcoma
Bone and Bones
Neoplasms
Angiogenesis Inhibitors
Bone Remodeling
Microvessels
Vascular Endothelial Growth Factor A
Nitric Oxide
Neoplasm Metastasis
Biopsy
Cell Line
Growth
Research
Therapeutics

Keywords

  • Angiogenesis
  • Endothelial cells
  • Sarcomas
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ex vivo behaviour of human bone tumor endothelial cells. / Infante, Teresa; Cesario, Elena; Gallo, Michele; Fazioli, Flavio; De Chiara, Annarosaria; Tutucci, Cristina; Apice, Gaetano; de Nigris, Filomena.

In: Cancers, Vol. 5, No. 2, 06.2013, p. 404-417.

Research output: Contribution to journalArticle

Infante, Teresa ; Cesario, Elena ; Gallo, Michele ; Fazioli, Flavio ; De Chiara, Annarosaria ; Tutucci, Cristina ; Apice, Gaetano ; de Nigris, Filomena. / Ex vivo behaviour of human bone tumor endothelial cells. In: Cancers. 2013 ; Vol. 5, No. 2. pp. 404-417.
@article{bde93b8840a240daa75ab0fea801fb78,
title = "Ex vivo behaviour of human bone tumor endothelial cells",
abstract = "Cooperation between endothelial cells and bone in bone remodelling is well established. In contrast, bone microvasculature supporting the growth of primary tumors and metastasis is poorly understood. Several antiangiogenic agents have recently been undergoing trials, although an extensive body of clinical data and experimental research have proved that angiogenic pathways differ in each tumor type and stage. Here, for the first time, we characterize at the molecular and functional level tumor endothelial cells from human bone sarcomas at different stages of disease and with different histotypes. We selected a CD31 + subpopulation from biopsies that displayed the capability to grow as adherent cell lines without vascular endothelial growth factor (VEGF). Our findings show the existence in human primary bone sarcomas of highly proliferative endothelial cells expressing CD31, CD44, CD105, CD146 and CD90 markers. These cells are committed to develop capillary-like structures and colony formation units, and to produce nitric oxide. We believe that a better understanding of tumor vasculature could be a valid tool for the design of an efficacious antiangiogenic therapy as adjuvant treatment of sarcomas.",
keywords = "Angiogenesis, Endothelial cells, Sarcomas, Tumor microenvironment",
author = "Teresa Infante and Elena Cesario and Michele Gallo and Flavio Fazioli and {De Chiara}, Annarosaria and Cristina Tutucci and Gaetano Apice and {de Nigris}, Filomena",
year = "2013",
month = "6",
doi = "10.3390/cancers5020404",
language = "English",
volume = "5",
pages = "404--417",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI AG",
number = "2",

}

TY - JOUR

T1 - Ex vivo behaviour of human bone tumor endothelial cells

AU - Infante, Teresa

AU - Cesario, Elena

AU - Gallo, Michele

AU - Fazioli, Flavio

AU - De Chiara, Annarosaria

AU - Tutucci, Cristina

AU - Apice, Gaetano

AU - de Nigris, Filomena

PY - 2013/6

Y1 - 2013/6

N2 - Cooperation between endothelial cells and bone in bone remodelling is well established. In contrast, bone microvasculature supporting the growth of primary tumors and metastasis is poorly understood. Several antiangiogenic agents have recently been undergoing trials, although an extensive body of clinical data and experimental research have proved that angiogenic pathways differ in each tumor type and stage. Here, for the first time, we characterize at the molecular and functional level tumor endothelial cells from human bone sarcomas at different stages of disease and with different histotypes. We selected a CD31 + subpopulation from biopsies that displayed the capability to grow as adherent cell lines without vascular endothelial growth factor (VEGF). Our findings show the existence in human primary bone sarcomas of highly proliferative endothelial cells expressing CD31, CD44, CD105, CD146 and CD90 markers. These cells are committed to develop capillary-like structures and colony formation units, and to produce nitric oxide. We believe that a better understanding of tumor vasculature could be a valid tool for the design of an efficacious antiangiogenic therapy as adjuvant treatment of sarcomas.

AB - Cooperation between endothelial cells and bone in bone remodelling is well established. In contrast, bone microvasculature supporting the growth of primary tumors and metastasis is poorly understood. Several antiangiogenic agents have recently been undergoing trials, although an extensive body of clinical data and experimental research have proved that angiogenic pathways differ in each tumor type and stage. Here, for the first time, we characterize at the molecular and functional level tumor endothelial cells from human bone sarcomas at different stages of disease and with different histotypes. We selected a CD31 + subpopulation from biopsies that displayed the capability to grow as adherent cell lines without vascular endothelial growth factor (VEGF). Our findings show the existence in human primary bone sarcomas of highly proliferative endothelial cells expressing CD31, CD44, CD105, CD146 and CD90 markers. These cells are committed to develop capillary-like structures and colony formation units, and to produce nitric oxide. We believe that a better understanding of tumor vasculature could be a valid tool for the design of an efficacious antiangiogenic therapy as adjuvant treatment of sarcomas.

KW - Angiogenesis

KW - Endothelial cells

KW - Sarcomas

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84876455233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876455233&partnerID=8YFLogxK

U2 - 10.3390/cancers5020404

DO - 10.3390/cancers5020404

M3 - Article

C2 - 24216983

AN - SCOPUS:84876455233

VL - 5

SP - 404

EP - 417

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 2

ER -